Kirby McInerney LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

[CONTACT FORM]

The lawsuit was filed on behalf of investors who acquired Applied Therapeutics securities from January 3, 2024, through and including December 2, 2024 (“the Class Period”). Investors have until February 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The lawsuit alleges that Defendants, throughout the Class Period, misled investors by providing positive statements to investors, while at the same time concealing material adverse facts concerning the true state of Applied Therapeutic’s trials; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study.

[LEARN MORE ABOUT THE CLASS ACTION]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
[email protected]

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow